These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 12116825

  • 1. Ischemic heart disease: the platelet paradox.
    de Gaetano G, Cerletti C, Iacoviello L, Donati MB.
    Ital Heart J; 2002 Jun; 3 Suppl 4():5S-8S. PubMed ID: 12116825
    [No Abstract] [Full Text] [Related]

  • 2. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
    Gurbel PA.
    Rev Cardiovasc Med; 2006 Jun; 7 Suppl 4():S20-8. PubMed ID: 17224887
    [Abstract] [Full Text] [Related]

  • 3. [Blood platelets and fibrinolysis in ischemic heart disease].
    Jastrzebska M.
    Pol Merkur Lekarski; 1996 Aug; 1(2):135-8. PubMed ID: 9156914
    [Abstract] [Full Text] [Related]

  • 4. Use of the platelet function analyser (PFA-100) to quantify the effect of low dose aspirin in patients with ischaemic heart disease.
    Coakley M, Self R, Marchant W, Mackie I, Mallett SV, Mythen M.
    Anaesthesia; 2005 Dec; 60(12):1173-8. PubMed ID: 16288614
    [Abstract] [Full Text] [Related]

  • 5. [Hemostasis disturbances in myocardial ischemia].
    Habis M, Gonzalez C, Jacq L, Pezzano M, Schaison F, Lardoux H.
    Ann Cardiol Angeiol (Paris); 2000 Dec; 49(8):480-7. PubMed ID: 12555436
    [Abstract] [Full Text] [Related]

  • 6. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
    Malý J, Pecka M, Gregor J, Dulícek P, Blazek M, Malý R, Pudil R, Bláha M.
    Cas Lek Cesk; 2005 Dec; 144 Suppl 3():23-9. PubMed ID: 16335259
    [Abstract] [Full Text] [Related]

  • 7. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM, Reininger AJ, Toth O, Deckmyn H, Brandl R, Siess W.
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [Abstract] [Full Text] [Related]

  • 8. [Preparations affecting arachidonic acid metabolism in the thrombocytes in the treatment of ischemic heart disease].
    Liusov VA, Uteshev DV, Volov NA, Teplova NN, Otarova SM.
    Eksp Klin Farmakol; 1995 Mar; 58(4):76-9. PubMed ID: 7580760
    [No Abstract] [Full Text] [Related]

  • 9. [Intravascular blood coagulation in patients with ischemic heart disease].
    Solov'ev AV, Ena IaM, Ermolin GA, Soroka VR.
    Ter Arkh; 1991 Mar; 63(9):64-9. PubMed ID: 1759228
    [No Abstract] [Full Text] [Related]

  • 10. The genetics of antiplatelet drug resistance.
    Feher G, Feher A, Pusch G, Lupkovics G, Szapary L, Papp E.
    Clin Genet; 2009 Jan; 75(1):1-18. PubMed ID: 19067731
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Blood flow and thrombogenesis. Correlation of blood platelets, blood coagulation factors and the vascular wall].
    Baumgartner HR.
    Internist (Berl); 1984 Feb; 25(2):75-81. PubMed ID: 6323341
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Platelet coagulation-protein interactions.
    Walsh PN.
    Semin Thromb Hemost; 2004 Aug; 30(4):461-71. PubMed ID: 15354267
    [Abstract] [Full Text] [Related]

  • 16. Platelet kinetics--1975.
    Ries CA.
    Ser Haematol; 1975 Aug; 8(3):98-104. PubMed ID: 1234386
    [Abstract] [Full Text] [Related]

  • 17. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ, Berneman Z, Schroyens W, Finazzi G, Budde U, van Vliet HH.
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [Abstract] [Full Text] [Related]

  • 18. Significance of platelet volume indices and platelet count in ischaemic heart disease.
    Ranjith MP, Divya R, Mehta VK, Krishnan MG, KamalRaj R, Kavishwar A.
    J Clin Pathol; 2009 Sep; 62(9):830-3. PubMed ID: 19734482
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Action of coagulation factors on experimental thrombogenesis and their changes after thrombosis.
    Marbet GA, Duckert F.
    Thromb Diath Haemorrh; 1973 Jun 28; 29(3):619-32. PubMed ID: 4761830
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.